Clinical trial · people

Orforglipron: food lowered drug exposure by 17.6% to 23.7%

Checked against the paper Clinical trialPublished by PepVault

The takeaway

Food modestly lowered orforglipron blood levels in healthy adults, and the authors judged this unlikely to make a meaningful difference in its effect.

Kind
Clinical trial
Studied in
People
Published
2024
Journal
Diabetes Ther

What they tested

Does taking orforglipron after eating instead of on an empty stomach change how much of the drug reaches the blood, and does it change safety?

How the study was done

Two phase 1 randomized crossover studies in healthy adults, where each person took the drug both fasted and fed. Study A gave a single 3 mg dose to 12 people, and study B gave repeated 16 mg doses to 34 people.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking orforglipron? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In the fed state, AUC (total drug exposure over time) was 23.7% lower and Cmax (peak blood level) was 23.2% lower in study A. In study B, AUC was 17.6% lower and Cmax was 20.9% lower with food. Half-life (how long the drug takes to clear by half) and the time to peak level were similar fed and fasted. Most side effects were gut-related, and there were no serious adverse events or deaths in either study.

What it doesn’t show

These were small, early-phase studies in healthy adults, and study B was 88.2% male. They measured blood levels and safety, not weight loss or blood sugar, so the authors' view that food won't change how well the drug works was not directly tested.

The paper

Ma et al. Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist. Diabetes Ther. 2024.

The compound

More studies on Orforglipron

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking orforglipron? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo